课题基金 / 基金详情

Covid-19: Intelligent Workforce Tracking and Tasking through Infrastructure Free Indoor Localisation

Covid-19: Intelligent Workforce Tracking and Tasking through Infrastructure Free Indoor Localisation
Covid-19:通过无基础设施的室内定位实现智能劳动力跟踪和任务分配
批准号:
77726
负责人:
金额:
$49.95万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
Navenio是一家开创性的英国企业,拥有独特的“一流”室内地理定位技术,可帮助组织更有效地管理人员和设备,而无需安装新的基础设施。这个由Innovate UK支持的项目将迅速增强Navenio的智能劳动力解决方案(IWS)的功能集,包括感染控制、快速响应清洁、搬运工任务和劳动力管理,帮助公司和医疗保健提供商更有效地应对Covid-19大流行带来的独特挑战。在短期内,该项目的产出将显著改善医院内的病人流动,包括病人出院,这将为新病人腾出床位,并有助于确保稀缺资源提供给最需要的人。从中期到长期来看,Navenio将利用该项目所带来的改进,迅速将其IWS系统的效用和效益扩展到医疗机构之外,包括扩展到零售、政府和教育部门。
英文摘要
Navenio is a pioneering UK business with a unique, "best-in-class" indoor geolocation technology that helps organisations to manage their people and equipment more effectively -- without the need to install new infrastructure.This Innovate UK supported project will rapidly enhance Navenio's Intelligent Workforce Solution (IWS) feature-set across infection control rapid-response cleaning, porter tasking and workforce management, helping companies and healthcare providers to respond more effectively to the unique challenges presented by the Covid-19 pandemic.In the short-term, this project's outputs will dramatically improve patient flow within hospitals, including patient discharge, which will free up beds for new patients and help make sure that scarce resources are available to those that need it most.In the mid-to-long term, Navenio will use the improvements developed as a result of this project to rapidly expand the utility and benefits of its IWS system beyond healthcare organisations, including expansion to retail, government and education sectors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
芽孢杆菌TR19-1对魔芋腐皮镰刀菌拮抗机理研究
1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
ATPIF1调节线粒体膜电位影响靶向CD19 CAR-T细胞抗肿瘤活性的作用及机制
  • 批准号:
    2026JJ80001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    钟根深
  • 依托单位:
CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
  • 批准号:
    2026JJ81339
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢希
  • 依托单位: